Maruhashiet al[2] have demonstrated that stable peptide-MHC II, rather than fibrinogen-like protein (FGL1), serves as the functional ligand for LAG3-mediated T cell suppression in both autoimmunity and anti-cancer immunity. Here, LAG3 is linked to cancer.